Rising demand for early genetic screenings, technological advancements, and increased awareness are key growth drivers. With ...

Desjardins Insurance is expanding its group benefits offering through a new partnership with precision diagnostics firm ...

A new genomic method has enabled multiple people with rare conditions to receive diagnoses that were previously unattainable ...

A new company, Nucleus Genomics, recently announced a whole new program of genetic testing. It is way past anything that you ...

A novel machine learning gene risk biomarker test successfully predicted patient response to semaglutide treatment after ...

Veracyte, Inc. (Nasdaq: VCYT), a leading cancer diagnostics company, today announced financial results for the third quarter ended September 30, 2025.

For the second straight year, every food vendor at the Louisiana Shrimp Festival & Shrimp Aid in New Orleans was verified as ...

The NWSL and Orlando Pride put out statements defending player Barbra Banda after another player published an op-ed calling ...

The California tiger salamander relies on seasonal ponds to breed. But for decades, the species has been under pressure from ...

The firm is now offering combined ex vivo drug sensitivity and genomic testing to cancer patients outside the clinical trial setting.

People looking to lose weight and lower their blood sugar may someday be able to get a single injection that turns their ...

While some practices remain controversial or speculative, biohackers are united by a shared curiosity: how can we engineer ...